Insider · CIK 0001452907

NEW ENTERPRISE ASSOCIATES 13 LP

Reports to the SEC for 22 companies · TIMONIUM, MD

sec.gov

Transactions

Companies

Filings

CIK

0001452907

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-03-14	BZFDBuzzFeed, Inc.S Sale	10% Owner	SSale	−273K sh	$2.26	−$618K	3,401,499
2025-03-13	BZFDBuzzFeed, Inc.S Sale	10% Owner	SSale	−61.4K sh	$2.01	−$124K	3,674,745
2025-03-12	BZFDBuzzFeed, Inc.S Sale	10% Owner	SSale	−28.3K sh	$1.98	−$55.9K	3,736,193
2025-03-11	BZFDBuzzFeed, Inc.S Sale	10% Owner	SSale	−13.6K sh	$1.95	−$26.6K	3,764,465
2025-03-07	BZFDBuzzFeed, Inc.S Sale	10% Owner	SSale	−33.8K sh	$2.06	−$69.6K	3,778,094
2025-03-06	BZFDBuzzFeed, Inc.S Sale	10% Owner	SSale	−11.1K sh	$2.10	−$23.4K	3,811,942
2025-03-05	BZFDBuzzFeed, Inc.S Sale	10% Owner	SSale	−8,966 sh	$2.04	−$18.3K	3,823,069
2025-03-04	BZFDBuzzFeed, Inc.S Sale	10% Owner	SSale	−1,438 sh	$2.07	−$2,978.098	3,832,035
2024-01-29	SGMTSagimet Biosciences Inc.J Other	10% Owner	JOther	−850K sh	—	—	3,000,275
2023-07-18	SGMTSagimet Biosciences Inc.J Other	10% Owner	JOther	−37.7K sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc.J Other	10% Owner	JOther	+37.7K sh	—	—	37,676
2023-07-18	SGMTSagimet Biosciences Inc.C Conversion	10% Owner	CConversion	+3.77M sh	—	—	3,807,533
2023-07-18	SGMTSagimet Biosciences Inc.X Exercise of In-Money	10% Owner	XExercise of In-Money	+13.4K sh	$0.79	+$10.7K	3,820,937
2023-07-18	SGMTSagimet Biosciences Inc.S Sale	10% Owner	SSale	−662 sh	$16.00	−$10.6K	3,820,275
2023-07-18	SGMTSagimet Biosciences Inc.P Purchase	10% Owner	PPurchase	+30K sh	$16.00	+$480K	3,850,275
2023-07-18	SGMTSagimet Biosciences Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−1.3M sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Series B-1 Preferred StockC Conversion	10% Owner	CConversion	−11.4M sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Series C Preferred StockC Conversion	10% Owner	CConversion	−11.4M sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Series D Preferred StockC Conversion	10% Owner	CConversion	−14.7M sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Series E Preferred StockC Conversion	10% Owner	CConversion	−238M sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Series F Preferred StockC Conversion	10% Owner	CConversion	−23M sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Common Stock Warrant (right to buy)X Exercise of In-Money	10% Owner	XExercise of In-Money	−13.4K sh	—	—	0
2023-02-09	UTRSMINERVA SURGICAL INCP Purchase	10% Owner	PPurchase	+24.4M sh	$0.20	+$5M	34,437,052
2022-10-25	PhaseBio Pharmaceuticals IncS Sale	10% Owner	SSale	−1.78M sh	$0.15	−$262K	4,857,525
2021-10-26	UTRSMINERVA SURGICAL INCC Conversion	10% Owner	CConversion	+596K sh	—	—	596,183
2021-10-26	UTRSMINERVA SURGICAL INCC Conversion	10% Owner	CConversion	+1.19M sh	—	—	1,786,395
2021-10-26	UTRSMINERVA SURGICAL INCC Conversion	10% Owner	CConversion	+3.41M sh	—	—	5,196,104
2021-10-26	UTRSMINERVA SURGICAL INCC Conversion	10% Owner	CConversion	+3.5M sh	—	—	8,699,125
2021-10-26	UTRSMINERVA SURGICAL INCP Purchase	10% Owner	PPurchase	+1.3M sh	$12.00	+$15.6M	9,999,125
2021-10-26	UTRSMINERVA SURGICAL INC · Series B Preferred StockC Conversion	10% Owner	CConversion	−596K sh	—	—	0
2021-10-26	UTRSMINERVA SURGICAL INC · Series C Preferred StockC Conversion	10% Owner	CConversion	−1.19M sh	—	—	0
2021-10-26	UTRSMINERVA SURGICAL INC · Series D Preferred StockC Conversion	10% Owner	CConversion	−3.41M sh	—	—	0
2021-10-26	UTRSMINERVA SURGICAL INC · Subordinated Secured Convertible Promissory NoteC Conversion	10% Owner	CConversion	—	—	—	0
2021-10-26	UTRSMINERVA SURGICAL INC · Subordinated Secured Convertible Promissory NoteC Conversion	10% Owner	CConversion	—	—	—	0
2021-10-26	UTRSMINERVA SURGICAL INC · Subordinated Secured Convertible Promissory NoteC Conversion	10% Owner	CConversion	—	—	—	0
2021-10-26	UTRSMINERVA SURGICAL INC · Subordinated Secured Convertible Promissory NoteC Conversion	10% Owner	CConversion	—	—	—	0
2021-10-26	UTRSMINERVA SURGICAL INC · Subordinated Secured Convertible Promissory NoteC Conversion	10% Owner	CConversion	—	—	—	0
2021-10-26	UTRSMINERVA SURGICAL INC · Subordinated Secured Convertible Promissory NoteC Conversion	10% Owner	CConversion	—	—	—	0
2021-10-26	UTRSMINERVA SURGICAL INC · Series D Preferred StockC Conversion	10% Owner	CConversion	+553K sh	—	—	553,449
2021-10-26	UTRSMINERVA SURGICAL INC · Series D Preferred StockC Conversion	10% Owner	CConversion	+532K sh	—	—	1,085,782
2021-10-26	UTRSMINERVA SURGICAL INC · Series D Preferred StockC Conversion	10% Owner	CConversion	+518K sh	—	—	1,603,374
2021-10-26	UTRSMINERVA SURGICAL INC · Series D Preferred StockC Conversion	10% Owner	CConversion	+503K sh	—	—	2,106,519
2021-10-26	UTRSMINERVA SURGICAL INC · Series D Preferred StockC Conversion	10% Owner	CConversion	+546K sh	—	—	2,652,530
2021-10-26	UTRSMINERVA SURGICAL INC · Series D Preferred StockC Conversion	10% Owner	CConversion	+850K sh	—	—	3,503,021
2021-10-26	UTRSMINERVA SURGICAL INC · Series D Preferred StockC Conversion	10% Owner	CConversion	−3.5M sh	—	—	0
2021-05-19	COURCoursera, Inc.J Other	10% Owner	JOther	−4.55M sh	—	—	13,661,886
2021-04-05	COURCoursera, Inc.C Conversion	10% Owner	CConversion	+17.9M sh	—	—	18,215,714
2021-04-05	COURCoursera, Inc. · Series A Preferred StockC Conversion	10% Owner	CConversion	−9.59M sh	—	—	0
2021-04-05	COURCoursera, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−1.02M sh	—	—	0
2021-04-05	COURCoursera, Inc. · Series C Preferred StockC Conversion	10% Owner	CConversion	−4.91M sh	—	—	0

Recent filings

Accepted (ET)
Mar 144
SANDELL SCOTT D0000950170-25-039628
SEC(opens sec.gov)
Mar 114
SANDELL SCOTT D0000950170-25-037454
SEC(opens sec.gov)
Mar 64
SANDELL SCOTT D0000950170-25-035077
SEC(opens sec.gov)
Jan 314
NEW ENTERPRISE ASSOCIATES 13 LP0001209191-24-002497
SEC(opens sec.gov)
Jul 204
KERINS PATRICK J0001209191-23-042970
SEC(opens sec.gov)

Insider transactions

Recent filings

Companies

Address